April 26, 2024

The Catholic Transcript

Complete News World

Health flyers for people over 40

Health flyers for people over 40

Today, the Ministry of Health announced the expansion of the application of the fourth dose of vaccination against Covid-19 for people over the age of 40 years. The extension of the age group at which you will begin receiving the second booster dose, as it is technically called, applies to those who have started an AstraZeneca, Pfizer or Coronavac immunization schedule.

For those starting the Janssen Immunization schedule, which contains a single dose, the volume also announced a third dose for people over 18 years of age and a fourth dose for people over 40.

According to the ministry, people in these age groups can now search for healthy jobs to receive the application of vaccines as of today.

Here is a summary of the new fans released for the booster app:

For those who have started vaccination with AstraZeneca, Pfizer or Coronavac:

  • Fourth dose: For people over 40 years old

For those who have started vaccination with Janssen:

  • Third dose: For people over 18 years old
  • Fourth dose: For people over 40 years old

The expansion of the target audience for the fourth dose comes at a time when Brazil, after dilution, is facing a rise in the number of deaths and known cases and after some states and municipalities Again recommending the use of indoor masks.

According to data from the Federation of Vehicles Press, of which UOL is part of Yesterday, Brazil recorded an increase in the moving average of deaths from the Corona virus for the ninth consecutive day The increase was 73%. The numbers for the Midwest (98%), the Southeast (1022%), and the South (39%) are also increasing.

See also  What Chronic Fatigue Syndrome Some People Have After Covid - News

In an interview with the newspaper the scientistExecutive Secretary of the Ministry of Health, Daniel Pereira, said that The application for the fourth dose should be released to the entire adult population over 18 years of age in the coming months. According to Pereira, there is still no decision on whether all age groups will have access to the immunization factor through the SUS (Unified Health System) or through private clinics.

At the beginning of this month, Saeed has already expanded the dosage application to adults over 50 and health workers of all ages. At the time, the ministry argued that this measure was necessary given “the need to strengthen the immunization of the age group and frontline workers of the health services, with greater risks of contamination”.